FDA.reportPublic FDA data

ocrelizumab 300 MG in 10 ML Injection

RxCUI
1876380
RxNorm name
ocrelizumab 300 MG in 10 ML Injection
Display name
ocrelizumab 300 MG in 10 ML Injection
Full name
ocrelizumab 300 MG in 10 ML Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:10

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761053Ocrevusocrelizumab351(a)Rx2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
OCREVUSOCRELIZUMABGenentech, Inc.9da42362-3bb5-4b83-b4bb-b59fd4e55f0d2026-05-14Warnings, Adverse reactionsExact identifier
rxcui: 1876380

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
9da42362-3bb5-4b83-b4bb-b59fd4e55f0docrelizumab 300 MG in 10 ML Injection [PSN] · 10 ML ocrelizumab 30 MG/ML Injection [SCD] · ocrelizumab 300 MG per 10 ML Injection [SY]324These highlights do not include all the information needed to use OCREVUS safely and effectively. See full prescribing information for OCREVUS. OCREVUS ® (ocrelizumab) injection, for intravenous use Initial U.S. Approval: 201720260514